Delivery Order SPE2DB22D1106-SPE2DB25FEHJ0
Award Date
4/10/25
Potential Completion Date
5/1/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of the drug BRUKINSA 80 MG CAPSULE 120S. This is a firm fixed-price delivery order contract with a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is a Delivery Order for the supply of 4567720736 BRUKINSA 80 MG CAPSULE 120S. It is a Firm Fixed Price contract with an ultimate completion date of April 17, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $12,740.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $6,370.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,985,646 units of the medication BRUKINSA 80 MG CAPSULE 120S. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 12, 2025. This award is not associated with a set-aside program and is considered open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed-price delivery order is for the supply of 4,567,986,180 units of the medication BRUKINSA 80 MG CAPSULE 120S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $7,492.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4566852339 - BRUKINSA 80 MG CAPSULE 120S and has a completion date of January 29, 2025. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $14,484.30 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 120 capsules of the drug BRUKINSA 80 MG. The contract has an ultimate completion date of October 2, 2024. This award is part of a larger indefinite delivery contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which allows the agency to efficiently procure a range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed-price delivery order is for the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is for the delivery of 4567907697 BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
This is a $6,370.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 120-count capsules of the drug BRUKINSA 80 MG. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...